HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer
- Significant expansion of allergy research expertise Geneva, Switzerland, November 23, 2022 – HpVac SA, a company developing novel preventive and therapeutic first-line therapies against allergic and inflammatory diseases, today…